Skip to content

Study on the efficacy and safety of hyperbaric oxygen in the treatment of cognitive impairment in patients with chronic schizophrenia

Study on the efficacy and safety of hyperbaric oxygen in the treatment of cognitive impairment in patients with chronic schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098078
Enrollment
Unknown
Registered
2025-03-03
Start date
2025-03-03
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mànxìng jingshén fenliè zhèng 7 / 5,000 Chronic schizophrenia

Interventions

Observation Group:Hyperbaric oxygen therapy was added to the control group. The patients entered a large multi-person air pressurized oxygen chamber, with pure oxygen masks, the cabin pressure was set

Sponsors

Chaohu Hospital Affiliated to Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. After a structured clinical interview by two or more attending psychiatrists, the patient meets the diagnostic criteria of DSM-5 or ICD-11 for schizophrenia; 2. The duration of illness is = 2 years, which meets the definition of chronic schizophrenia; 3. The age range is 18-60 years old; 4. There is no obvious acute mental symptom in the past 3 months, and the condition is stable and can cooperate with the research requirements; 5. The patient is receiving a stable dose of antipsychotic drugs for at least 1 month, and there is no plan to adjust the dose; 6. The patient and the guardian can understand the content of the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe physical illness: such as severe cardiovascular and cerebrovascular diseases, lung diseases (such as pneumothorax, chronic obstructive pulmonary disease), etc., who cannot tolerate hyperbaric oxygen therapy; 2. Other mental disorders: such as comorbidities such as bipolar disorder, major depression or neurodevelopmental disorders; 3. Drug dependence: alcohol or substance use disorder (excluding nicotine) currently or in the past year; 4. Pregnancy or lactation: female patients are pregnant or lactating; 5. History of epilepsy: past or current history of epileptic seizures; 6. Contraindications to hyperbaric oxygen: including uncontrolled hypertension, otitis media, severe autism, etc.; 7. Others: any condition that may affect study compliance or data accuracy (such as intellectual disability, severe language communication barriers).

Design outcomes

Primary

MeasureTime frame
Positive and Negative Syndrome Scale (PANSS);

Secondary

MeasureTime frame
Personal and Social Performance Scale;

Countries

China

Contacts

Public ContactZhang Kai

Chaohu Hospital Affiliated to Anhui Medical University

zhangkai@ahmu.edu.cn+86 189 2110 4636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026